Cargando…

Benefits of (11)C-methionine PET/MRI and intraoperative fluorescence in treating hyperparathyroidism

Multiple endocrine neoplasia 1 (MEN1) is a rare genetic syndrome characterized by the manifestation of tumors in endocrine glands most often in the parathyroid gland (PG). Treatment may involve several parathyroidectomies (PTX), especially in young patients, which increases the risk of postoperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Luong, Thien Vinh, Rejnmark, Lars, Arveschoug, Anne Kirstine, Iversen, Peter, Rolighed, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424345/
http://dx.doi.org/10.1530/EDM-20-0053
_version_ 1783570320622354432
author Luong, Thien Vinh
Rejnmark, Lars
Arveschoug, Anne Kirstine
Iversen, Peter
Rolighed, Lars
author_facet Luong, Thien Vinh
Rejnmark, Lars
Arveschoug, Anne Kirstine
Iversen, Peter
Rolighed, Lars
author_sort Luong, Thien Vinh
collection PubMed
description Multiple endocrine neoplasia 1 (MEN1) is a rare genetic syndrome characterized by the manifestation of tumors in endocrine glands most often in the parathyroid gland (PG). Treatment may involve several parathyroidectomies (PTX), especially in young patients, which increases the risk of postoperative complications. We present a 16-year-old patient with a family history of MEN1 syndrome. The patient started to show biochemical signs of hyperparathyroidism (HPT) and hypercalcemia at the age of 10. One and a half years later a PTX was successfully performed with removal of the two left PGs. However, a rise in plasma parathyroid hormone and ionized calcium was observed 4 years later. Preoperative noninvasive imaging with (99m)Tc-sestamibi scintigraphy showed no definitive parathyroid adenoma. A (11)C-methionine position emission tomography combined with MRI (MET-PET/MRI) was then performed and detected a focus posterior to the lower part of the right thyroid lobe. Intraoperative angiography with fluorescence and indocyanine green dye was used to assess the vascularization of the remaining PGs. The lower right PG was removed. The patient was discharged with normalized biochemical values and without postoperative complications. Recurrence of primary HPT is frequent in MEN1 patients which often necessitates repeated operations. Our case report showed that the use of advanced noninvasive preoperative imaging techniques and intraoperative fluorescent imaging are valuable tools and should be taken into consideration in selected cases to avoid postoperative complications. To our knowledge, this is the first case where MET-PET/MRI has been used to detect parathyroid pathology. LEARNING POINTS: MEN1 patients will develop parathyroid disease, which eventually will lead to surgical treatment with removal of the pathological glands. Preoperatively usage of MRI combined with PET tracers such as (11)C-methionine and (18)F-Fluorocholine are able to detect parathyroid pathology with a higher sensitivity than conventional imaging. Techniques using intraoperatively angiography with fluorescence and florescent dyes allow surgeons to verify the vascularization of each parathyroid gland. Optimization of noninvasive preoperative imaging techniques and intraoperative fluorescent imaging are valuable tools and should be taken into consideration when performing PTX consecutively in the same patient to avoid postoperative complications.
format Online
Article
Text
id pubmed-7424345
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-74243452020-08-17 Benefits of (11)C-methionine PET/MRI and intraoperative fluorescence in treating hyperparathyroidism Luong, Thien Vinh Rejnmark, Lars Arveschoug, Anne Kirstine Iversen, Peter Rolighed, Lars Endocrinol Diabetes Metab Case Rep Novel Diagnostic Procedure Multiple endocrine neoplasia 1 (MEN1) is a rare genetic syndrome characterized by the manifestation of tumors in endocrine glands most often in the parathyroid gland (PG). Treatment may involve several parathyroidectomies (PTX), especially in young patients, which increases the risk of postoperative complications. We present a 16-year-old patient with a family history of MEN1 syndrome. The patient started to show biochemical signs of hyperparathyroidism (HPT) and hypercalcemia at the age of 10. One and a half years later a PTX was successfully performed with removal of the two left PGs. However, a rise in plasma parathyroid hormone and ionized calcium was observed 4 years later. Preoperative noninvasive imaging with (99m)Tc-sestamibi scintigraphy showed no definitive parathyroid adenoma. A (11)C-methionine position emission tomography combined with MRI (MET-PET/MRI) was then performed and detected a focus posterior to the lower part of the right thyroid lobe. Intraoperative angiography with fluorescence and indocyanine green dye was used to assess the vascularization of the remaining PGs. The lower right PG was removed. The patient was discharged with normalized biochemical values and without postoperative complications. Recurrence of primary HPT is frequent in MEN1 patients which often necessitates repeated operations. Our case report showed that the use of advanced noninvasive preoperative imaging techniques and intraoperative fluorescent imaging are valuable tools and should be taken into consideration in selected cases to avoid postoperative complications. To our knowledge, this is the first case where MET-PET/MRI has been used to detect parathyroid pathology. LEARNING POINTS: MEN1 patients will develop parathyroid disease, which eventually will lead to surgical treatment with removal of the pathological glands. Preoperatively usage of MRI combined with PET tracers such as (11)C-methionine and (18)F-Fluorocholine are able to detect parathyroid pathology with a higher sensitivity than conventional imaging. Techniques using intraoperatively angiography with fluorescence and florescent dyes allow surgeons to verify the vascularization of each parathyroid gland. Optimization of noninvasive preoperative imaging techniques and intraoperative fluorescent imaging are valuable tools and should be taken into consideration when performing PTX consecutively in the same patient to avoid postoperative complications. Bioscientifica Ltd 2020-07-29 /pmc/articles/PMC7424345/ http://dx.doi.org/10.1530/EDM-20-0053 Text en © 2020 The authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (http://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Novel Diagnostic Procedure
Luong, Thien Vinh
Rejnmark, Lars
Arveschoug, Anne Kirstine
Iversen, Peter
Rolighed, Lars
Benefits of (11)C-methionine PET/MRI and intraoperative fluorescence in treating hyperparathyroidism
title Benefits of (11)C-methionine PET/MRI and intraoperative fluorescence in treating hyperparathyroidism
title_full Benefits of (11)C-methionine PET/MRI and intraoperative fluorescence in treating hyperparathyroidism
title_fullStr Benefits of (11)C-methionine PET/MRI and intraoperative fluorescence in treating hyperparathyroidism
title_full_unstemmed Benefits of (11)C-methionine PET/MRI and intraoperative fluorescence in treating hyperparathyroidism
title_short Benefits of (11)C-methionine PET/MRI and intraoperative fluorescence in treating hyperparathyroidism
title_sort benefits of (11)c-methionine pet/mri and intraoperative fluorescence in treating hyperparathyroidism
topic Novel Diagnostic Procedure
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424345/
http://dx.doi.org/10.1530/EDM-20-0053
work_keys_str_mv AT luongthienvinh benefitsof11cmethioninepetmriandintraoperativefluorescenceintreatinghyperparathyroidism
AT rejnmarklars benefitsof11cmethioninepetmriandintraoperativefluorescenceintreatinghyperparathyroidism
AT arveschougannekirstine benefitsof11cmethioninepetmriandintraoperativefluorescenceintreatinghyperparathyroidism
AT iversenpeter benefitsof11cmethioninepetmriandintraoperativefluorescenceintreatinghyperparathyroidism
AT rolighedlars benefitsof11cmethioninepetmriandintraoperativefluorescenceintreatinghyperparathyroidism